Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma

Environmental and Molecular Mutagenesis

Volumn 54, Issue 1, 2013, Pages 72-77

  Hu, Wei ^a   Bassig, Bryan A ^a   Xu, Jun ^a   Zheng, Tongzhang ^b   Zhang, Yawei ^b   Berndt, Sonja I ^a   Holford, Theodore R ^b   Hosgood, H Dean ^a   Leaderer, Brian ^b   Yeager, Meredith ^a   Menashe, Idan ^a   Boyle, Peter ^c   Zou, Kaiyong ^b   Zhu, Yong ^b   Chanock, Stephen ^a   Lan, Qing ^a   Rothman, Nathaniel ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b YALE UNIVERSITY   (United States)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Innate immunity; MASP2; MBP; NHL; Pattern recognition

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; FEMALE; FOLLICULAR LYMPHOMA; GENETIC VARIABILITY; GENOTYPE; HUMAN; INNATE IMMUNITY; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PATTERN RECOGNITION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; BETA-DEFENSINS; CASE-CONTROL STUDIES; CONNECTICUT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; IMMUNITY, INNATE; LOGISTIC MODELS; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, NON-HODGKIN; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; MIDDLE AGED; MYELIN BASIC PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, PATTERN RECOGNITION; YOUNG ADULT;

EID: 84871939161     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.21739     Document Type: Article

References (38)

1. Bassig BA, Zheng T, Zhang Y, Berndt SI, Holford TR, Hosgood HDIII, Hu W, Leaderer B, Yeager M, Menashe I, Boyle P, Xu J, Zou K, Zhu Y, Chanock S, Rothman N, Lan Q. 2012. Polymorphisms in complement system genes and risk of non-Hodgkin lymphoma. Environ Mol Mutagen 53: 145-151.
2. Beutler B. 2004. Innate immunity: An overview. Mol Immunol 40: 845-859.
3. Chen BE, Sakoda LC, Hsing AW, Rosenberg PS. 2006. Resampling-based multiple hypothesis testing procedures for genetic case-control association studies. Genet Epidemiol 30: 495-507.
4. Cerhan JR, Ansell SM, Fredericksen ZS, Kay NE, Liebow M, Call TG, Dogan A, Cunningham JM, Wang AH, Liu-Mares W, Macon WR, Jelinek D, Witzig TE, Habermann TM, Slager SL. 2007. Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood 110: 4455-4463.
5. Cerhan JR, Novak AJ, Fredericksen ZS, Wang AH, Liebow M, Call TG, Dogan A, Witzig TE, Ansell SM, Habermann TM, Kay NE, Slager SL. 2009. Risk of non-Hodgkin lymphoma in association with germline variation in complement genes. Br J Haematol 145: 614-623.
6. Crowther-Swanepoel D, Mansouri M, Enjuanes A, Vega A, Smedby KE, Ruiz-Ponte C, Jurlander J, Juliusson G, Montserrat E, Catovsky D, Campo E, Carracedo A, Rosenquist R, Houlston RS. 2010. Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia risk. Br J Haemaltol 150: 473-479.
7. De Sanjose S, Benavente Y, Vajdic CM, Engels EA, Morton LM, Bracci PM, Spinelli JJ, Zheng T, Zhang Y, Franceschi S, Talamini R, Holly EA, Grulich AE, Cerhan JR, Hartge P, Cozen W, Boffetta P, Brennan P, Maynadie M, Cocco P, Bosch R, Foretova L, Staines A, Becker N, Nieters A. 2008. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol 6: 451-458.
8. Di Bernardo MC, Crowther-Swanepoel D, Broderick P, Webb E, Sellick G, Wild R, Sullivan K, Vijayakrishnan J, Wang Y, Pittman AM, Sunter NJ, Hall AG, Dyer MJ, Matutes E, Dearden C, Mainou-Fowler T, Jackson GH, Summerfield G, Harris RJ, Pettitt AR, Hillmen P, Allsup DJ, Bailey JR, Pratt G, Pepper C, Fegan C, Allan JM, Catovsky D, Houlston RS. 2008. A genome-wide association study identifies six susceptibility loci for chronic lymphocyticleukemia. Nat Genet 40: 1204-1210.
9. Engels EA, Cho ER, Jee SH. 2010. Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: A cohort study. Lancet Oncol 11: 827-834.
10. Epeldegui M, Vendrame E, Martinez-Maza O. 2010. HIV-associated immune dysfunction and viral infection: Role in the pathogenesis of AIDS-related lymphoma. Immunol Res 48: 72-83.
11. Excoffier L, Slatkin M. 1995. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12: 921-927.
12. Feng JM. 2007. Minireview: Expression and function of golli protein in immune system. Neurochem Res 32: 273-278.
13. Feng JM, Hu YK, Xie LH, Colwell CS, Shao XM, Sun XP, Chen B, Tang H, Campagnoni AT. 2006. Golli protein negatively regulates store depletion-induced calcium influx in T cells. Immunity 24: 717-727.
14. Forrest MS, Skibola CF, Lightfoot TJ, Bracci PM, Willett EV, Smith MT, Holly EA, Roman E. 2006. Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma. Br J Haematol 134: 180-183.
15. Franceschi S, Lise M, Trepo C, Berthillon P, Chuang SC, Nieters A, Travis RC, Vermeulen R, Overvad K, Tjonneland AM, Olsen A, Bergmann M, Boeing H, Kaaks R, Becker N, Trichopoulou A, Lagiou P, Bamia C, Palli D, Sieri SA, Panico S, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, Peeters PH, Rodriguez L, Lujan Barroso L, Dorronsoro M, Sanchez MJ, Navarro C, Barricarte Gurrea A, Regner S, Borgquist S, Melin B, Hallmans G, Khaw KT, Wareham NJ, Rinaldi S, Hainaut P, Riboli E, Vineis P. 2011. Infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol Biomarkers Prev 20: 208-214.
16. Friese MA, Steinle A, Weller M. 2004. The innate immune response in the central nervous system and its role in glioma immune surveillance. Onkologie 27: 487-491.
17. Granell M, Urbano-Ispizua A, Suarez B, Rovira M, Fernandez-Aviles F, Martinez C, Ortega M, Uriburu C, Gaya A, Roncero JM, Navarro A, Carreras E, Mensa J, Vives J, Rozman C, Montserrat E, Lozano F. 2006. Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation. Exp Hematol 34: 1435-1441.
18. Grulich AE, Van Leeuwen MT, Falster MO, Vajdic CM. 2007. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: A meta-analysis. Lancet 370: 59-67.
19. Han S, Lan Q, Park AK, Lee KM, Park SK, Ahn HS, Shin HY, Kang HJ, Koo HH, Seo JJ, Choi JE, Ahn YO, Chanock SJ, Kim H, Rothman N, Kang D. 2010. Polymorphisms in innate immunity genes and risk of childhood leukemia. Hum Immunol 71: 727-730.
20. Holtmeier W, Kabelitz D. 2005. γδ T cells link innate and adaptive immune responses. Chem Immunol Allergy 86: 151-183.
21. Ip WK, Takahashi K, Ezekowitz RA, Stuart LM. 2009. Mannose-binding lectin and innate immunity. Immunol Rev 230: 9-21.
22. Ito M, Murakami K, Suzuki T, Mochida K, Suzuki M, Ikebuchi K, Yamaguchi K, Mizuochi T. 2010. Enhanced expression of lymphomagenesis-related genes in peripheral blood B cells of chronic hepatitis C patients. Clin Immunol 135: 459-465.
23. Kabelitz D, Medzhitov R. 2007. Innate immunity-Cross-talk with adaptive immunity through pattern recognition receptors and cytokines. Curr Opin Immunol 19: 1-3.
24. Lan Q, Zheng T, Rothman N, Zhang Y, Wang SS, Shen M, Berndt SI, Zahm SH, Holford TR, Leaderer B, Yeager M, Welch R, Boyle P, Zhang B, Zou K, Zhu Y, Chanock S. 2006. Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood 107: 4101-4108.
25. Lan Q, Au WY, Chanock S, Tse J, Wong KF, Shen M, Siu LP, Yuenger J, Yeager M, Hosgood HD3rd, Purdue MP, Liang R, Rothman N. 2010. Genetic susceptibility for chronic lymphocytic leukemia among Chinese in Hong Kong. Eur J Haematol 85: 492-495.
26. Lee JY, Park AK, Lee KM, Park SK, Han S, Han W, Noh DY, Yoo KY, Kim H, Chanock SJ, Rothman N, Kang D. 2009. Candidate gene approach evaluates association between innate immunity genes and breast cancer risk in Korean women. Carcinogenesis 30: 1528-1531.
27. Medzhitov R, Janeway CJr. 2000. Innate immunity. N Engl J Med 343: 338-344.
28. Nieters A, Beckmann L, Deeg E, Becker N. 2006. Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor α and lymphoma risk. Genes Immun 7: 615-624.
29. Purdue MP, Lan Q, Kricker A, Grulich AE, Vajdic CM, Turner J, Whitby D, Chanock S, Rothman N, Armstrong BK. 2007. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: Findings from the New South Wales non-Hodgkin Lymphoma Study. Carcinogenesis 28: 704-712.
30. Purdue MP, Lan Q, Wang SS, Kricker A, Menashe I, Zheng TZ, Hartge P, Grulich AE, Zhang Y, Morton LM, Vajdic CM, Holford TR, Severson RK, Leaderer BP, Cerhan JR, Yeager M, Cozen W, Jacobs K, Davis S, Rothman N, Chanock SJ, Chatterjee N, Armstrong BK. 2009. A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma. Carcinogenesis 30: 275-281.
31. Rajaraman P, Brenner AV, Butler MA, Wang SS, Pfeiffer RM, Ruder AM, Linet MS, Yeager M, Wang Z, Orr N, Fine HA, Kwon D, Thomas G, Rothman N, Inskip PD, Chanock SJ. 2009. Common variation in genes related to innate immunity and risk of adult glioma. Cancer Epidemiol Biomarkers Prev 18: 1651-1658.
32. Rothman N, Skibola CF, Wang SS, Morgan G, Lan Q, Smith MT, Spinelli JJ, Willett E, De Sanjose S, Cocco P, Berndt SI, Brennan P, Brooks-Wilson A, Wacholder S, Becker N, Hartge P, Zheng T, Roman E, Holly EA, Boffetta P, Armstrong B, Cozen W, Linet M, Bosch FX, Ennas MG, Holford TR, Gallagher RP, Rollinson S, Bracci PM, Cerhan JR, Whitby D, Moore PS, Leaderer B, Lai A, Spink C, Davis S, Bosch R, Scarpa A, Zhang Y, Severson RK, Yeager M, Chanock S, Nieters A. 2006. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: A report from the InterLymph Consortium. Lancet Oncol 7: 27-38.
33. Shen M, Zhang LP, Lee KM, Vermeulen R, Hosgood HD, Li GL, Yin S, Rothman N, Chanock S, Smith MT, Lan Q. 2011. Polymorphisms in genes involved in innate immunity and susceptibility to benzene-induced hematotoxicity. Exp Mol Med 43: 374-378.
34. Skibola CF, Bracci PM, Halperin E, Conde L, Craig DW, Agana L, Iyadurai K, Becker N, Brooks-Wilson A, Curry JD, Spinelli JJ, Holly EA, Riby J, Zhang L, Nieters A, Smith MT, Brown KM. 2009. Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma. Nat Genet 41: 873-875.
35. Thiel S, Kolev M, Degn S, Steffensen R, Hansen AG, Ruseva M, Jensenius JC. 2009. Polymorphisms in mannan-binding lectin (MBL)-associated serine protease 2 affect stability, binding to MBL, and enzymatic activity. J Immunol 182: 2939-2947.
36. Wang SS, Cozen W, Cerhan JR, Colt JS, Morton LM, Engels EA, Davis S, Severson RK, Rothman N, Chanock SJ, Hartge P. 2007. Immune mechanisms in non-Hodgkin lymphoma: Joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Cancer Res 67: 5042-5054.
37. Yang D, Chetov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, Anderson M, Schröder JM, Wang JM, Howard OM, Oppenheim JJ. 1999. β-Defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286: 525-528.
38. Zehnder A, Fisch U, Hirt A, Niggli FK, Simon A, Ozsahin H, Schlapbach LJ, Ammann RA. 2009. Prognosis in pediatric hematologic malignancies is associated with serum concentration of mannose-binding lectin-associated serine protease-2 (MASP-2). Pediatr Blood Cancer 53: 53-57.